HGH, GRENAA A/S: Financial statements 2019
CVR: 33120753
Source: annual report 2019, Danish Business Authority
01/10/2018 – 30/09/2019
HGH, GRENAA A/S (CVR 33120753) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -251,838 compared with DKK -71,709 the year before. Equity in the 2019 report amounted to DKK 1,145,267. The solvency ratio was 64.8%.
- Profit/Loss
- DKK -251,838
- Equity
- DKK 1,145,267
- Total Assets
- DKK 1,767,654
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -252 t. | 1.1 mio. | - |
| 2018 | - | - | -72 t. | 1.4 mio. | - |
| 2017 | - | - | -306 t. | 1.5 mio. | - |
| 2016 | - | - | -446 t. | 1.8 mio. | - |
| 2015 | - | - | -459 t. | 2.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
HGH, GRENAA A/S has published its annual report for 2018. The net result was DKK -71,709.
About HGH, GRENAA A/S
HGH, GRENAA A/S is a Danish company of the type Aktieselskab based in Grenaa, founded in 2010. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Louise Rørbæk Jensen. The board consists of Mette Rørbæk Jensen (chair), Jess Stegger and Louise Rørbæk Jensen. The company is owned by Boet efter Ulla Merethe Rørbæk Jensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,125 and a net result of DKK -1,506,927 compared with DKK 84,836 the year before. Equity in the 2025 report amounted to DKK -789,690.